FDA Drug recall D-183-2013
0.9% Sodium Chloride Injection USP, 100 mL Hospira, Inc., Lake Forest, IL 60045 NDC 0409-7984-23
- FDA Drug
- Class II
- terminated
- Published 2013-03-13
On 2013-03-13 the FDA classified a Class II recall of 0.9% Sodium Chloride Injection USP, 100 mL Hospira, Inc., Lake Forest, IL 60045 NDC 0409-7984-23 by Hospira, citing lack of Assurance of Sterility: There is the potential for solution to leak from the administrative port to the fill tube seal.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-183-2013 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2013-01-08 |
| Published | 2013-03-13 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Hospira |
| Distribution | US |
Product
0.9% Sodium Chloride Injection USP, 100 mL Hospira, Inc., Lake Forest, IL 60045 NDC 0409-7984-23,
Reason
Lack of Assurance of Sterility: There is the potential for solution to leak from the administrative port to the fill tube seal.
Identifiers
| code_info | Lot Number 02-117-JT Exp. 02/13 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-183-2013%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.